Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$21.91 USD
+0.85 (4.04%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $21.88 -0.03 (-0.14%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth B Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Rigel Pharmaceuticals, Inc. has a market cap of $376.39M, which represents its share price of $21.06 multiplied by its outstanding shares number of 17.87M. As a small-cap company, RIGL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RIGL 21.91 +0.85(4.04%)
Will RIGL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RIGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RIGL
Collegium Pharmaceutical (COLL) Q2 Earnings Preview: What's in the Cards?
Why Rigel (RIGL) Could Beat Earnings Estimates Again
RIGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect?
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?
Other News for RIGL
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and ...
RIGL Crosses Above Key Moving Average Level
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | ...
RIGL Makes Bullish Cross Above Critical Moving Average
Nuvation Bio: Judgement Day Grows Closer